Android app on Google Play

BofA/Merrill Lynch Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral

March 4, 2013 7:04 AM EST Send to a Friend
Get Alerts BMY Hot Sheet
Price: $50.58 -0.14%

Rating Summary:
    10 Buy, 7 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 24 | Down: 14 | New: 52
Trade BMY Now!
Join SI Premium – FREE
BofA/Merrill Lynch downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Neutral.

For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.

Shares of Bristol-Myers Squibb Co. closed at $37.15 yesterday.




You May Also Be Interested In


Related Categories

Downgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment